Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases.

@article{Borden1998GeneRA,
  title={Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases.},
  author={Borden},
  journal={The oncologist},
  year={1998},
  volume={3 3},
  pages={198-203}
}
  • Borden
  • Published 1998 in The oncologist
OVERVIEW: Clinical indications for the use of interferons (IFNs) for cancer continue to expand and will likely continue to do so. IFNs have been approved for clinical use by the United States Food and Drug Administration for chronic myelogenous leukemia (CML), hairy cell leukemia, follicular lymphomas, Kaposi's sarcoma in the setting of AIDS, and melanoma for patients at high risk for recurrence after surgery. In addition, as a result of their antiviral activity, IFNs result in control of… CONTINUE READING